PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10653547::ACT002740

MAP-0403_J-2

Evidence text

Paper-level observation

Text: MAP-0403 J-2 reduced cell viability to 73.43% at 200 μg/mL
textConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Cytotoxic
Measure
cell_viability
Comparator
=
Raw observation
73.43 %
Normalized measurement
=73.43%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
MRC-5
Assay method
Not reported by source
Sequence
KWLRRPWRRWRNH
Standardization
ready simple

Source publication

Synergistic effect of two antimicrobial peptides, BP203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates.

PLOS ONE · 2023

DOI 10.1371/journal.pone.0294287 PMC10653547
Parent mention

Related peptide identities

PEPDIA-PLP-001674

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.